Research
Proteogenomic analysis of 5,411 plasma proteins in sickle cell disease patients
PLOS ·
The Brief
- The study reports a proteogenomic analysis of 5,411 plasma proteins in sickle cell disease patients, published in PLOS Genetics.
- Sickle cell disease is a blood disorder caused by mutations in the β-globin gene and affects more than 7 million individuals, according to the paper.
- The authors note that there are few therapeutic options to treat sickle cell disease.
Why it matters
Large-scale plasma protein and genetic data in sickle cell disease patients can help researchers identify candidate biomarkers and potential drug targets in a disease with few treatment options.
Who’s affected
- researchers in sickle cell disease, hematology and human genetics
- #sickle cell disease
- #proteomics
- #genetics
- #plasma proteins
- #hematology
by Cristian Groza, Arnaud Chignon, Ken Sin Lo, Vanessa Bellegarde, Pablo Bartolucci, Guillaume Lettre There are few therapeutic options to treat patients with sickle cell disease (SCD), a blood disorder caused by mutations in the β-globin gene that affects > 7M individuals…